TRB-805

N/A

Report date: 2025/01/26 17:47:50

Base Information

Drug NameTRB-805

Drug Alias Namedual CD47 checkpoint inhibitor/SIRP alpha checkpoint inhibitor (Trican Biotechnology)TRB-805

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionSignal-regulatory protein alpha inhibitorsCluster of differentiation 47 inhibitors

TargetsSignal-regulatory protein alphaCluster of differentiation 47

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTrican Biotechnology Inc

China Registration ClassN/A

Develop Information

Active CompaniesTrican Biotechnology Inc

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A